Fertility Drugs Global Market Report 2025

Description

Fertility drugs encompass medications designed to stimulate the body's hormone release, regulating and prompting ovulation-the release of eggs from the ovaries.

These drugs fall into two main categories include prescription fertility drugs and over-the-counter variants. They are administered through various methods including oral ingestion, intravenous injection, subcutaneous injection (into the fatty tissue just below the skin), and intramuscular injection, catering to both male and female patients. Distribution channels for these drugs span hospital pharmacies, retail outlets, and online pharmacies, ensuring accessibility across different avenues for patients seeking fertility treatment.

The fertility drugs market research report is one of a series of new reports from The Business Research Company that provides fertility drugs market statistics, including fertility drugs industry global market size, regional shares, competitors with a fertility drugs market share, detailed fertility drugs market segments, market trends and opportunities, and any further data you may need to thrive in the fertility drugs industry. This fertility drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The fertility drugs market size has grown strongly in recent years. It will grow from $3.13 billion in 2024 to $3.36 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increasing infertility rates, advances in reproductive medicine, assisted reproductive technologies (ART), and delayed childbearing.

The fertility drugs market size is expected to see strong growth in the next few years. It will grow to $4.39 billion in 2029 at a compound annual growth rate (CAGR) of 6.9% . The growth in the forecast period can be attributed to the aging population, lifestyle factors, assisted reproductive technologies (art), and personalized medicine. Major trends in the forecast period include advancements in assisted reproductive technologies (ART), ovulation-inducing medications, and hormone therapy.

The market for fertility drugs is experiencing growth due to the rising rates of infertility worldwide. Infertility is defined as the inability to conceive after 12 consecutive months of trying. Fertility drugs are commonly used to address infertility issues in both men and women. The increasing incidence of infertility can be attributed to physiological and hormonal issues, as well as lifestyle and environmental factors. In women, fertility drugs are often employed to regulate ovulation cycles, which directly impacts the sales of these medications. For example, a report from the Office for National Statistics in February 2024 indicated that the total fertility rate (TFR) in the UK fell to 1.49 children per woman in 2022, down from 1.55 in 2021. Consequently, the growing prevalence of infertility around the world is driving demand for fertility drugs, thereby contributing to the growth of the fertility drug market.

Anticipated growth in the fertility drugs market is further propelled by the mounting prevalence of obesity, a condition significantly associated with infertility in men and women. This trend stems from the imperative for specialized treatments, augmented awareness, supportive governmental policies, and ongoing research endeavors aimed at addressing fertility challenges linked to obesity. Data from the World Heart Federation in March 2023 reveals a staggering 2.3 billion individuals, both adults and children, affected by obesity or overweight conditions globally. Projections indicate an upward trend, with estimates foreseeing a rise to 2.7 billion by 2025. Thus, the burgeoning prevalence of obesity serves as a driving force propelling growth within the fertility drugs market.

Leading companies in the fertility drugs market are concentrating on creating innovative solutions, such as peptide-based injectable treatments, to improve reproductive health outcomes. Peptide-based injectable treatments involve medications that use synthetic or naturally occurring peptides to stimulate or regulate hormonal activity, particularly concerning fertility and reproductive health. For example, in February 2024, Lupin Limited, a pharmaceutical company based in India, introduced a ganirelix acetate injection in the United States. This medication is frequently used in assisted reproductive technology (ART) protocols to prevent premature ovulation during controlled ovarian stimulation for women undergoing in vitro fertilization (IVF). As a GnRH antagonist, ganirelix acetate helps regulate hormone levels, allowing for better management of the ovarian stimulation process. The launch in the U.S. underscores Lupin's commitment to expanding its product range in the reproductive health sector and addressing the needs of patients undergoing fertility treatments.

Major players in the fertility drugs market are launching comprehensive campaigns centered around fertility care, aiming to secure competitive advantages. These campaigns, designed to raise awareness and educate the public on fertility-related issues, treatments, and reproductive health, play a crucial role in safeguarding access to fertility care. Pinnacle Fertility's August 2022 initiative, the Save IVF campaign in the US, is a prime example. Focused on potential legislation affecting family-building treatments like IVF in the absence of federal protection, this campaign advocates for preserving fertility care access. By mobilizing communities and encouraging individuals to support the cause through the #SaveIVF Pledge, Pinnacle Fertility seeks to protect fertility treatments' accessibility and combat legislative threats.

In March 2023, Sumitovant Biopharma Ltd., a US-based biopharmaceutical company, finalized the acquisition of Myovant Sciences Ltd. for an undisclosed sum. This strategic acquisition amplifies Sumitovant's collaborative capabilities, resources, and expertise, enabling them to effectively tackle unmet needs in women's health and prostate cancer. The combined entity aims to advance their joint pipeline's development, extending the reach of their distinct therapies to benefit diverse patient communities. Myovant Sciences Ltd., a US-based biotechnology firm, specializes in developing and commercializing novel treatments for women's diseases and endocrine disorders. Their focus areas include addressing conditions like heavy menstrual bleeding associated with uterine fibroids and female infertility. This acquisition marks a pivotal step for both companies in bolstering their offerings and impact within these critical medical domains.

Major companies operating in the fertility drugs market include Merck & Co., Ferring Pharmaceuticals Inc., Bayer AG, Berlex Laboratories Inc., Janssen Pharmaceutical Inc., Pfizer Inc., Novartis AG, Procter & Gamble Health Limited, Zydus Lifesciences Limited, Livzon Pharmaceutical Group Inc., Abbott Laboratories, Sanofi S.A., Eli Lilly and Company, Serono Inc., Novagen Healthcare Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., AstraZeneca plc, Aurobindo Pharma Ltd., Schering-Plough Corporation, Regeneron Pharmaceuticals Inc., F. Hoffmann-La Roche AG, Vitrolife, Cook Medical, Organon Group, The Cooper Companies Inc., Irvine Scientific, Genea Biomedx, Mankind Pharma

North America was the largest region in the fertility drugs market in 2024. The Middle East is expected to be the fastest-growing region in the drugs for infertility market during the forecast period. The regions covered in the fertility drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the fertility drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The fertility drugs market consists of sales of clomiphene citrate, gonadotropins, and metformin. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Fertility Drugs Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on fertility drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for fertility drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The fertility drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type Of Drug: Prescription Fertility Drugs; Over-The-Counter Fertility drugs
2) By Route of Administration: Oral; Intravenous; Subcutaneous; Intramuscular
3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
Subsegments:
1) By Prescription Fertility Drugs: Gonadotropins; Clomiphene Citrate; Letrozole; GnRH Agonists; GnRH Antagonists; Progesterone
2) By Over-The-Counter Fertility Drugs: Ovulation Predictor Kits; Fertility Supplements; Fertility Monitors
Companies Mentioned: Merck & Co.; Ferring Pharmaceuticals Inc.; Bayer AG; Berlex Laboratories Inc.; Janssen Pharmaceutical Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r32913

1. Executive Summary

2. Fertility Drugs Market Characteristics

3. Fertility Drugs Market Trends And Strategies

4. Fertility Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Fertility Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Fertility Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Fertility Drugs Market Growth Rate Analysis
5.4. Global Fertility Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Fertility Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Fertility Drugs Total Addressable Market (TAM)

6. Fertility Drugs Market Segmentation

6.1. Global Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Prescription Fertility Drugs
Over-The-Counter Fertility Drugs
6.2. Global Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Intravenous
Subcutaneous
Intramuscular
6.3. Global Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
6.4. Global Fertility Drugs Market, Sub-Segmentation Of Prescription Fertility Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Gonadotropins
Clomiphene Citrate
Letrozole
GnRH Agonists
GnRH Antagonists
Progesterone
6.5. Global Fertility Drugs Market, Sub-Segmentation Of Over-The-Counter Fertility Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Ovulation Predictor Kits
Fertility Supplements
Fertility Monitors

7. Fertility Drugs Market Regional And Country Analysis

7.1. Global Fertility Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Fertility Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Fertility Drugs Market

8.1. Asia-Pacific Fertility Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Fertility Drugs Market

9.1. China Fertility Drugs Market Overview
9.2. China Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Fertility Drugs Market

10.1. India Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Fertility Drugs Market

11.1. Japan Fertility Drugs Market Overview
11.2. Japan Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Fertility Drugs Market

12.1. Australia Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Fertility Drugs Market

13.1. Indonesia Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Fertility Drugs Market

14.1. South Korea Fertility Drugs Market Overview
14.2. South Korea Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Fertility Drugs Market

15.1. Western Europe Fertility Drugs Market Overview
15.2. Western Europe Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Fertility Drugs Market

16.1. UK Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Fertility Drugs Market

17.1. Germany Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Fertility Drugs Market

18.1. France Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Fertility Drugs Market

19.1. Italy Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Fertility Drugs Market

20.1. Spain Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Fertility Drugs Market

21.1. Eastern Europe Fertility Drugs Market Overview
21.2. Eastern Europe Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Fertility Drugs Market

22.1. Russia Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Fertility Drugs Market

23.1. North America Fertility Drugs Market Overview
23.2. North America Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Fertility Drugs Market

24.1. USA Fertility Drugs Market Overview
24.2. USA Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Fertility Drugs Market

25.1. Canada Fertility Drugs Market Overview
25.2. Canada Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Fertility Drugs Market

26.1. South America Fertility Drugs Market Overview
26.2. South America Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Fertility Drugs Market

27.1. Brazil Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Fertility Drugs Market

28.1. Middle East Fertility Drugs Market Overview
28.2. Middle East Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Fertility Drugs Market

29.1. Africa Fertility Drugs Market Overview
29.2. Africa Fertility Drugs Market, Segmentation By Type Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Fertility Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Fertility Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Fertility Drugs Market Competitive Landscape And Company Profiles

30.1. Fertility Drugs Market Competitive Landscape
30.2. Fertility Drugs Market Company Profiles
- 30.2.1. Merck & Co. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Ferring Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Berlex Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Janssen Pharmaceutical Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Fertility Drugs Market Other Major And Innovative Companies

31.1. Pfizer Inc.
31.2. Novartis AG
31.3. Procter & Gamble Health Limited
31.4. Zydus Lifesciences Limited
31.5. Livzon Pharmaceutical Group Inc.
31.6. Abbott Laboratories
31.7. Sanofi S.A.
31.8. Eli Lilly and Company
31.9. Serono Inc.
31.10. Novagen Healthcare Pvt. Ltd.
31.11. Takeda Pharmaceutical Co. Ltd.
31.12. AstraZeneca plc
31.13. Aurobindo Pharma Ltd.
31.14. Schering-Plough Corporation
31.15. Regeneron Pharmaceuticals Inc.

32. Global Fertility Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Fertility Drugs Market

34. Recent Developments In The Fertility Drugs Market

35. Fertility Drugs Market High Potential Countries, Segments and Strategies

35.1 Fertility Drugs Market In 2029 - Countries Offering Most New Opportunities
35.2 Fertility Drugs Market In 2029 - Segments Offering Most New Opportunities
35.3 Fertility Drugs Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer